If anyone want to know more about Deloraine acquisition.
they paid $24m, write off $20m as non cash impairment.
Most likely now focus on more partnership in China for more competitive advatanges.
if an asset is not generating decent revenue or providing benefits over their competitors then why keeping them?
they should not release this news seperately making it looks bad
all impairments usually just part of the half yearly or yearly statement.
not gloom and doom news to me. Timing of this report is not right nor smart in a way.
Ann: Acquisition of CNCA Approved Facility - Cornerstone Investor, page-30
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $115.9M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.3¢ | 13.0¢ | $68.13K | 523.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 32 | 1001536 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 445331 | 18 |
View Market Depth
| Last trade - 12.34pm 03/06/2024 (20 minute delay) ? |
|
|||||
|
Last
13.0¢ |
Change
0.000 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 13.3¢ | 13.3¢ | 13.0¢ | 371926 | ||
| Last updated 12.47pm 03/06/2024 ? | |||||
| BUB (ASX) Chart |